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Functional tea beverages have emerged as a novel approach to achieve health benefits 21 
associated with tea. The use of metabolomics may improve the evaluation of their 22 
consumption and their effects beyond self-reported questionnaires. The current study 23 
aimed to explore the urinary signature of the exposure to a functional high-catechin tea 24 
(HCT) using an untargeted NMR-based metabolomics approach. Ten male volunteers 25 
participated in a dietary crossover randomized intervention study. Individuals consumed 26 
a HCT or a control beverage during 28 days. Multilevel partial least squares 27 
discriminant analysis (ML-PLS-DA) was used for paired comparisons across the 28 
crossover design. A further univariant crossover-model was performed to assess the 29 
significant changes. The acute intake of HCT resulted in the excretion of theanine, 30 
gallate, epicatechin and epigallocatechin, as well as higher levels of 3-methyl-2-31 
oxovalerate. The sustained consumption of the HCT exhibited the excretion of 32 
pyrogallol, higher succinate levels and a lower excretion of 2-hydroxyisobutyrate. After 33 
the repeated exposure to HCT, the acute intake of HCT exhibited a new performance of 34 
food metabolome compounds mentioned above. In conclusion, the present work settled 35 
known regular tea biomarkers, and novel urinary signatures. Such signatures may be 36 
potential biomarkers and/or reflect certain benefits of functional tea beverages. 37 
 38 
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Tea (Camellia sinensis) is a common beverage with high consumption per capita 42 
worldwide.1 The chemical composition of tea is affected by the fermentation process. 43 
The different types of tea are classified into green and white tea (unfermented), oolong 44 
tea (semi-fermented), black tea (fully fermented) and pu-erh tea (post-fermented).2,3 45 
Green tea is rich in several catechins (flavan-3-ols), being the most abundant 46 
polyphenols in this beverage, whereas, theaflavins and thearubigins are abundant in 47 
black tea.4 Furthermore, epigallocatechin gallate (EGCG) is the most important catechin 48 
in green tea but also other catechins and their epimeric forms are found such as 49 
epigallocatechin (EGC), epicatechin gallate (ECG), epicatechin (EC), catechin (C), 50 
gallocatechin (GC), catechin gallate (CG), and gallocatechin gallate (GCG).5  51 
Advances in ready-to-drink teas have been developed to innovate with brewing 52 
requirements of premium leaf while responding as a suitable way for fortification that 53 
can add more health benefits to these functional drinks.6,7 In addition, there is an 54 
increasing use of polyphenols and functional beverages due to the high demands for 55 
polyphenol-rich consumables.8 There are numerous studies concerning its benefits for 56 
health9,10 finding that most of the observed health-effects are attributed to its 57 
polyphenols.11 Concretely, the U.S. Food and Drug Administration approved the health 58 
claims for green tea consumption against risk of breast and prostate cancers.12 There are 59 
also several studies relating tea consumption with benefits on other chronic diseases, 60 
such as cardiovascular, metabolic and neurodegenerative diseases, but showing lack of 61 
consistency in the levels commonly consumed by human populations.13 The traditional 62 
methods to determine the consumption are based on the use of food frequency 63 
questionnaires.14 Regular tea intake is usually measured in the number of cups of tea 64 
consumed per day4 whereby this methodology may provide unpredictability to 65 
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epidemiologic studies.  Several biomarkers of tea intake have been proposed using mass 66 
spectrometry.15 In acute intervention studies with green tea, EC, EGC and conjugated 67 
metabolites are predominant in short-term urine samples.16,17 Longer exposures to green 68 
tea showed the presence of microbial co-metabolites such as certain valerolactones in 69 
24-h urine samples.18,19 These metabolites were associated with tea in cross-sectional 70 
studies.20,21 A lower number of studies described 1,3-dihydroxyphenyl-2-O-sulfate 71 
(pyrogallol sulfate), hippuric acid, 4-hydroxyhippuric acid and gallic acid22–24 as main 72 
tea biomarkers using 1H-NMR-based metabolomics. Nevertheless, these metabolites are 73 
not highly specific for tea since they were found after other food sources such as coffee, 74 
cocoa, wine, fruits or vegetables.25–28 The application of metabolomics in the nutrition 75 
field may let to discover accurate biomarkers of intake and also may reveal potential 76 
modifications in diet-related pathways in healthy individuals likewise in early disease 77 
stages.14,29 Metabolomics allows a global description of metabolites that gives detailed 78 
information on metabolic pathways and in turn on biological processes, thereby 79 
clarifying associations with health benefits and elucidating underlying mechanisms.30 80 
More concretely, while the biomarkers of intake reflect the dietary exposure, altered 81 
endogenous compounds may reveal the mechanistic role of functional foods.31 82 
Therefore, the present study was conducted to determine the metabolic fingerprint of a 83 
functional green tea high in catechin polyphenols on the urinary metabolome after both 84 
acute and sustained consumptions. 85 
MATERIALS AND METHODS 86 
Subjects and study design 87 
Ten healthy male volunteers between 25 and 44 years old with a body mass index 88 
(BMI) of 23.0±2.0 kg/m2 (mean ± SD) participated in a randomized, double-blind, 89 
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placebo-controlled, crossover clinical trial (Figure 1). Exclusion criteria included 90 
caffeine intoxication, intake of catechins supplements, serious illness (such as heart 91 
disease, kidney disease or diabetes) and food allergies. The study protocol was 92 
approved by the Human Research Ethics Committee of Biological Science Laboratories 93 
of the KAO Corporation (ref: 507-20131218). This clinical trial was registered with the 94 
International Standard Randomized Controlled Trial Number (ISRCTN) 15516017. 95 
During the washout and the study periods, the subjects were forbidden to consume 96 
coffee and tea beverages other than test drinks. Subjects were not allowed to consume 97 
alcoholic beverages and to practice exercise from 2 days before the beginning of the 98 
intervention. After a 14-day washout period, subjects were asked to consume a 99 
functional high-catechins tea beverage (hereafter HCT) containing 187 mg/100 ml of 100 
catechins (KAO Corporation, Japan) or a control beverage (caffeine-containing 101 
beverage). The daily dose of caffeine was similar between the intervention and control 102 
groups (see Table S1, Supporting Information). Then, the participants consumed the 103 
corresponding beverage every day for the next 28 days (period I). The same procedure 104 
was repeated switching the individuals between the groups (period II) after a second 14-105 
day washout period, in accordance with the crossover design. To analyse acute 106 
consumption, urine samples collected during the first 4 postprandial hours after intake 107 
were obtained on the first day of the intervention. Fasting urine samples were collected 108 
on the first and last days of each period for the analysis of sustained consumption. 109 
Finally, in order to analyse the repeated exposures reflecting the habitual intakes to this 110 
drink, urine samples collected during the first 4 postprandial hours after intake were 111 
collected during the final day of each period. All urine samples were stored in aliquots 112 




Sample preparation and data acquisition 115 
Sample processing and data acquisition were performed as previously described.27 Both 116 
urine and beverage samples were thawed, vortexed and centrifuged at 13,200 rpm for 5 117 
min. The supernatant (600 μL) from each sample was mixed with an internal standard 118 
solution [120 μL, consisting of 0.1% TSP (3-(trimethylsilyl)-proprionate-2,2,3,3-d4, 119 
chemical shift reference), 2 mM of sodium azide (NaN3, bacteriostatic agent) and 1.5 M 120 
KH2PO4 in 99% deuterium water (D2O)]. The optimized pH of the buffer was set at 7.0, 121 
with a potassium deuteroxide (KOD) solution, to minimize variations in the chemical 122 
shifts of the NMR resonances. This mixture was transferred to a 5 mm NMR tube. 123 
Urinary spectra were acquired on a Varian-Inova-500 MHz NMR spectrometer with 124 
presaturation of the water resonance using a NOESYPRESAT pulse sequence. During 125 
the acquisition, the internal temperature was kept constant at 298 K. An exponential 126 
window function was applied to the free induction decay (FID) with a line-broadening 127 
factor of 0.3 Hz prior to the Fourier transformation. For each sample, a total of 128 128 
scans were recorded into 32 K data points with a spectral width of 14 ppm, an 129 
acquisition time of 2 s and a relaxation delay of 5 s. HCT spectra were acquired on a 130 
Bruker Avance III 400 MHz NMR spectrometer equipped with a cryoprobe with 131 
presaturation of the water resonance using a NOESYPRESAT pulse sequence. The 132 
internal temperature was kept constant at 298 K and the sample was processed with a 133 
line-broadening factor of 0.3 Hz, 64 scans with a spectral width of 15 ppm, an 134 
acquisition time of 3 s and a relaxation delay of 5 s. 135 
Spectra were manually phased, baseline corrected and calibrated (TSP, 0.0 ppm) using 136 
TopSpin software (version 3.0, Bruker, BioSpin, Germany). Spectra data were bucketed 137 
in intelligent bucketing domains of 0.005 ppm with ACD/NMR Processor 12.0 software 138 
7 
 
(Advanced Chemistry Development, Toronto, Canada). The water signal and the noise 139 
regions above 9.5 ppm and below 0.5 ppm were excluded from the analysis.  140 
Data processing and statistical analysis 141 
Data from (i) acute intervention, (ii) sustained intervention and (iii) acute intervention 142 
after the repeated exposure were submitted separately to MetaboAnalyst 3.0 for 143 
normalization purposes.32 Data were row-wise normalized by the sum of the intensities 144 
of the spectra and column-wise normalized using cube root transformation and Pareto 145 
scaling.  146 
Datasets were then imported to R software version 3.1.2.33 Principal component 147 
analysis (PCA) was performed on baseline samples to acquire an overview of 148 
individuals and to detect potential carryover effects. After performing the differences 149 
between baseline and intervention data of each volunteer (Δ data), multilevel partial 150 
least squares discriminant analysis (ML-PLS-DA)34 was used on Δ data for paired 151 
comparisons of  HCT versus control beverage using the ‘mixOmics’ R-package.35 The 152 
“leave-one-subject-out” cross-validation was used to assess the models and the 153 
classification error rate was calculated by comparing the actual class with the predicted 154 
one. Significant variables were obtained based on the lowest classification error rate and 155 
on loading scores from the first latent variable.27 Absolute values of loading scores were 156 
ranked and the top 5% of total features were selected as long as those variables were 157 
kept at the lowest classification error rate. These features were employed to model a 158 
sparse ML-PLS-DA. Signals from the sparse ML-PLS-DA were ranked based on the 159 
absolute values of their loading scores termed loading rank, LR.27 160 
The univariate crossover model36,37 of Δ data was also performed between groups to 161 
assess the statistical significances. In addition to individual effect, the period (I and II) 162 
and the sequence (from control to test interventions, or from test to control 163 
8 
 
interventions) followed by each volunteer were considered in the crossover model for 164 
further correction on carryover effects. Statistical significance was considered at a p-165 
value <0.05. 166 
Metabolite identification 167 
Metabolite identification were performed using Chenomx NMR Suite Professional 168 
Software package (version 8.1; Chenomx Inc, Edmonton, Canada) and by comparing 169 
NMR spectral data to those available in databases such as the Human Metabolome 170 
Database (http://www.hmdb.ca), along with the existing NMR-based metabolomics 171 
literature. Further, a Pearson’s correlation test was performed to assess correlations 172 
between signals of the same metabolite. 173 
RESULTS AND DISCUSSION 174 
1H NMR profiling of the HCT 175 
Metabolic profiling of the HCT beverage was carried out for further exploration of the 176 
urinary signatures coming from the functional beverage. The identified compounds with 177 
the corresponding chemical shifts are summarized in Table S2. Several compounds 178 
naturally present in tea, susceptible to be found in urine, were identified in the HCT. 179 
EC, EGCG and EGC are frequently reported in regular green tea beverages although in 180 
lower concentrations (Table S3).38 The characteristic signals corresponding to gallate 181 
and theanine, which were previously described in tea beverages,3,39 were observed on 182 
the HCT spectra and subsequently found in the urine in the present study (see below). 183 
Other compounds such as caffeine, theobromine, catechol and quinate were also 184 
identified in the HCT as previous described in regular tea.39 185 
 186 
Assessment of multi- and univariate approaches 187 
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PCA did not indicate the presence of carryover effects (Figure S1). There was no sign 188 
difference between the control group and the HCT group on baseline samples in terms of 189 
period and sequence. The differences between the control group and the HCT group 190 
resulted in three ML-PLS-DA models on the Δ data, with a minimum classification error 191 
rate of 0.1 for the sustained intervention and 0.0 for both the first acute study and the 192 
second acute study after the sustained treatment. The lowest estimated classification error 193 
rate remained for a range between the 2nd and the 39th variable after the first acute 194 
intervention, whereas in the sustained intervention the minimum estimated classification 195 
rate was from the 7th to the 10th variable. For the second acute study after the prolonged 196 
HCT consumption, the classification error rate was kept to 0.0 during the first 93 variables. 197 
Hence, three sparse ML-PLS-DA models were constructed with the selected variables. 198 
Discriminant features projected in the first component were ranked according the loading 199 
score values and set in the LRs.  200 
The statistical univariate crossover models revealed that a total of 8 compounds were 201 
significantly different between HCT and control beverages. As expected, there was a 202 
strong agreement between uni- and multivariate analyses performed separately, in 203 
which lowest p-values matched with the highest loading scores, and thus, lowest 204 
loading rank, as it is shown in Table 1. Figure 2 shows box plots of the metabolites 205 
levels for HCT and control groups. 206 
Urinary compounds from the food metabolome 207 
After the punctual intake (single dose) of HCT, several compounds coming from the 208 
beverage were found in the 4h-urine. A prominent signal at δ2.04 and a triplet at δ1.12 209 
were originally assigned to theanine (Table 1). Then, a triplet at δ3.79 and a multiplet at 210 
δ3.18 were also correlated between the signals corroborating the identification. 211 
Theanine is a nonproteinogenic amino acid present in green tea40 and the mushrooms 212 
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Xerocomus badius41 that improves memory and attention.42 Interestingly, this 213 
compound was also identified in the HCT used in the study (Table S2). Therefore 214 
theanine may display a possible direct excretion from tea (Figure 3).  Van der Pijl and 215 
co-workers found maximum plasmatic concentrations of theanine after 50 min of the 216 
intake of 25, 50, and 200 mg L-theanine provided via an aqueous solution or black tea.43 217 
Similar results were observed by Scheid and co-workers finding a maximum plasma 218 
concentration of theanine at 0.8 h after capsules and green tea intake; also found in the 219 
urine of participants collected within the interval 3-24 h after intake.44 In consonance 220 
with these findings, we identified theanine in urine sample collected within the first 4 h, 221 
entailing an early excretion of this potential biomarker. Gallate and EC were also 222 
detected in 4h-urine and also the HCT beverage (Figure 3) denoting the successful 223 
absorption and excretion of those compounds as suggested by Rhodes and co-authors.45 224 
Nevertheless, although the methylated, glucuronide and sulfate catechins forms are 225 
frequently detected by mass spectrometry,19,46,47 they were not detected in the present 226 
study. EGC was weakly detected in urine in spite of being strongly distinguished 227 
through the singlet δ6.59 in the beverage. In contrast, urinary EGC was firmly detected 228 
by other authors using liquid chromatography.16,17,21 Interestingly, ECG and EGCG, 229 
which were identified in the HCT beverage, were not detected in the urine of 230 
participants. While Del Rio et al., (2010) and Stalmach et al., (2009) described the 231 
presence of unmetabolized EGCG and ECG in plasma after tea ingestion, neither EGCG 232 
nor ECG were easily detected in the urinary metabolome.19,48,49 This fact implicates that 233 
the unmetabolized forms of EGCG and ECG probably are not suitable urinary 234 
biomarkers of tea intake. We tentatively assigned pyrogallol (sulfate) to the doublet 235 
shown at δ6.59 and signals at δ7.05 based on the previous work of the authors Daykin, 236 
2005; and Van Dorsten, 2006.22,23 This metabolite is derived from the cleavage of the 3-237 
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O-gallate groups.58 These authors also suggested other metabolites such as hippuric acid 238 
as major urinary metabolite; however, this was not observed in our study. Pyrogallol 239 
(sulfate) was significant according the crossover model (Table 1). Nevertheless, the 240 
statistical power of the multivariate approach was not strong due to the presence of this 241 
metabolite only in certain individuals. This inter-individual variation in the excretion 242 
may be related to the colonic microbiota response of participants.59 Therefore, the 243 
variability in the biological effects of tea consumption are related to the presence or the 244 
absence of certain microorganisms and their metabolites in the gut.60 Lastly, the 245 
punctual intake of the beverage after a prolonged exposure seated the findings of the 246 
first acute intake, replicating short-terms biomarkers of intake such as theanine, EC and 247 
gallate. However, in the fasted urine collected after the sustained exposure, none of 248 
these compounds were found to be statistically significant in any participant entailing 249 
the return to baseline levels within the 24 h after the last intake. In fact, most excretions 250 
of the flavan-3-ol metabolites occur within the first 12 h after intake.50 Therefore, as we 251 
expected, these metabolites were newly observed in 4h-urine after a new intake. 252 
Overall, the present findings confirm known intake biomarkers coming from the food 253 
metabolome, but also propose new potential compounds that should be further studied 254 
as novel biomarkers of intake. 255 
Endogenous and microbial metabolites  256 
Regarding endogenous compounds, mainly metabolites from tricarboxylic acid (TCA) 257 
cycle and microbiota activity were altered. After the intake of the HCT, 3-methyl-2-258 
oxovalerate, which is a product of isoleucine metabolism, was statistically increased in 259 
4h-urine after both punctual and prolonged consumption. Isoleucine is metabolized to 260 
succinate via the methylmalonyl-CoA51 in TCA cycle. Urinary succinate was also raised 261 
after prolonged consumption in both 4h- and 24h-urine samples. Similar studies giving 262 
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a single dose of a rich-polyphenol food such as coffee and wine exhibited higher urinary 263 
levels of 3-methyl-2-oxovalerate  and succinate.27,52 The branched-chain keto-acid 3-264 
methyl-2-oxovalerate was also the strongest predictive biomarker for type 2 diabetes 265 
and impaired fasting glucose,53 while succinate was found to be increased after the 266 
consumption of regular green tea and green tea with ascorbate in rats.54 The fact that 267 
nutritional studies included healthy volunteers  may point to a strong impact on energy 268 
regulation by polyphenols even in short-term,55 especially observed in tea.56,57 269 
Therefore, the increased levels of 3-methyl-2-oxovalerate and succinate reflect this 270 
regulation by the functional tea rather than an illness situation in the present study. After 271 
the sustained consumption of HCT, several compounds were related to microbiota 272 
metabolism of catechins. The crossover model revealed a decrease of the singlet δ1.36 273 
in the HCT group, identified as 2-hydroxyisobutyrate. Li and co-workers used 274 
combination of spectroscopic, microbiomic, and multivariate statistical tools to model 275 
the microbial–host connections and showed this compound associated to the presence of 276 
Faecalibacterium prausnitzii in the colon.61 This metabolite was associated to the 277 
microbial degradation of undigested proteins in the gastrointestinal tract.61 The 278 
compound was also reported as discriminant between obese and lean individuals 279 
demonstrating functional differences in the microbiome metabolic activity.62 The 280 
urinary metabotype of obese individuals was characterized by a higher concentration of 281 
2-hydroxyisobutyrate and lower levels of hippuric acid, trigonelline and xanthine. In 282 
this sense, lower excretion of 2-hydroxyisobutyrate may be associated to a gut 283 
microbiota modulation by the constituents present in the functional green tea and might 284 
be the responsible of certain health benefits in terms of obesity and Crohn disease.63 In 285 
summary, the present endogenous metabolites might be connected with certain benefits 286 
derived of functional beverages. 287 
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Our study shows evidence for metabolic changes by a functional beverage composed by 288 
higher concentrations of catechins than a regular green tea. Unlike the expected results, 289 
theanine was a prominent urinary biomarker, beyond the catechins present as food 290 
metabolome compounds from the functional beverage. The HCT also had an impact on 291 
the endogenous metabolome. Certain metabolites connected to TCA cycle and to the 292 
microbial activity were found to be altered in urine suggesting some of the connections 293 
to the described health benefits by tea. In conclusion, we not only seated the presence of 294 
tea markers but also present metabolic changes based on endogenous alterations. 295 
theanine as intake biomarker as well as different biomarkers of effect. 296 
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Figure 1. Schematic representation of the randomized, placebo-controlled and 538 
crossover design of the study. HCT, high catechin tea. 539 




Figure 2. Box plots of urinary metabolites that were significantly different after high 542 
catechin tea (HCT) compared with control beverage in acute, sustained and repeated 543 
exposures. 3-M-2oxovalerate: 3-methyl-2-oxovalerrate; EC, epicathechin; EGC, 544 




Figure 3. Main compounds found in the HCT urine of the participants in both acute and 547 
sustained interventions. 548 
